Is an electronic signature valid?

Yes. Electronic signatures are legally valid for most Testing Release Documents under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA rules. Recognize statutory exceptions like wills or certain court filings before relying solely on e-signatures.

When is notarization required?

Notarization depends on state law and document purpose. Testing Release Documents rarely require notarization unless they affect real property, convey rights requiring formal acknowledgement, or include powers of attorney; confirm with the state notary authority.

What if signer names don't match?

Name mismatches can impair attribution and enforcement. Obtain government ID, correct the name via an amendment or notarized acknowledgement, and ensure tax reporting uses a completed W-9 to avoid backup withholding consequences.

How long must signed copies be kept?

Retention depends on content: IRS records generally require 3 years from filing (IRC §6501(a)); HIPAA requires 6 years for PHI (45 CFR §164.530(j)). Keep records longer where contract or state law requires it.

How to fix errors after signing?

Use a signed amendment or corrective addendum executed by all parties; do not alter the original signed document. For material changes, consult counsel to preserve enforceability and evidentiary integrity.

Can I use Remote Online Notarization?

Many states permit RON but requirements vary (identity proofing, audio-video recording, retention). Verify the state's RON rules and notary commission guidance before relying on remote notarization for evidentiary needs.

Electronic Signature
Templates
Miscellaneous
Testing Release Document

Testing Release Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

TESTING RELEASE DOCUMENT

Parties

Client Name Client Contact and Address Test Provider Name Provider Contact and Address

Recitals

WHEREAS, Client seeks to engage Provider to perform testing, evaluation, analysis and related services on products, prototypes, samples and associated materials (collectively, the "Test Items") for the purposes described herein; and

WHEREAS, Provider represents that it possesses the facilities, expertise, personnel and insurance necessary to perform such testing in accordance with the terms of this Testing Release Document; and

WHEREAS, the parties desire to define the scope of work, allocation of risk, confidentiality, payment and other rights and obligations governing the testing engagement.

Scope of Work

Description of Testing Services Test Items to be Provided by Client

Test Location: Anticipated Test Start Date: Anticipated Test End Date:

Payment Terms

Client shall pay Provider as follows:

Total Fee Payment Schedule and Milestones

Late Payment: Unpaid amounts shall accrue interest at the lesser of 1.5% per month or the maximum rate permitted by law, plus all reasonable collection costs, including attorneys' fees.

Late Fee (if applicable)

Term and Termination

This Agreement commences on the Start Date and continues until the End Date or until earlier terminated in accordance with this Section.

Start Date: End Date:

Termination Notice Period

Either party may terminate this Agreement for material breach by the other party if the breach remains uncured for the notice period above after delivery of written notice. Termination shall not relieve Client of its obligation to pay for services rendered through the effective date of termination.

Confidentiality

"Confidential Information" means non-public information disclosed by one party (Disclosing Party) to the other (Receiving Party) that is marked confidential or that a reasonable person would understand to be confidential under the circumstances, including test data, technical specifications, prototypes, formulas, trade secrets, and business plans.

Receiving Party shall: (a) hold Confidential Information in strict confidence, using at least the same degree of care it uses to protect its own confidential information but no less than reasonable care; (b) not disclose Confidential Information to any third party except to employees, contractors and agents who have a need to know and who are bound by confidentiality obligations no less protective than those in this Agreement; and (c) use Confidential Information solely to perform its obligations under this Agreement.

Confidentiality obligations shall survive termination of this Agreement for a period of from the date of disclosure, except as otherwise required by law.

Release, Liability and Indemnification

Client acknowledges that testing may involve inherent risks. To the fullest extent permitted by law, Client releases Provider and its officers, employees and agents from any claims, liabilities or expenses arising out of Provider's performance of the testing services, except to the extent caused by Provider's gross negligence or willful misconduct.

Provider shall maintain commercially reasonable insurance for its operations. Provider shall indemnify and hold harmless Client from and against third-party claims directly resulting from Provider's gross negligence or willful misconduct in the performance of the testing services.

Ownership of Results; Use of Test Data

Unless otherwise agreed in writing, all test results, raw data, analyses and reports generated in connection with the testing (the "Results") shall be the property of . Provider may retain copies of Results solely for internal quality control but shall not disclose Results except as permitted by this Agreement.

Provider makes no warranty, express or implied, regarding fitness for a particular purpose, merchantability or the results of any testing except as expressly set forth in a separate written agreement signed by both parties.

Return or Disposal of Test Items

Client shall indicate whether Test Items are to be returned or disposed of after testing. Return or disposal instructions:

Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the State of , without regard to its conflict of laws principles.

Entire Agreement

This Testing Release Document, together with any exhibits and written statements of work expressly incorporated herein, constitutes the entire agreement between the parties with respect to its subject matter and supersedes all prior or contemporaneous oral or written agreements. No modification of this Agreement shall be effective unless in writing and signed by authorized representatives of both parties.

Certifications

Each party represents and warrants that it has full power and authority to enter into this Agreement and to perform its obligations hereunder, and that execution and delivery of this Agreement has been duly authorized by all necessary action.

Client:

By:

Date:

Provider:

By:

Date:

What a Testing Release Document Is and When It Applies

A Testing Release Document is a written agreement used to record permission, scope, and liability terms when releasing test results, prototypes, or product trials to third parties. It clarifies what data or artifacts are shared, who may access them, permitted uses, confidentiality limits, and any required acknowledgements or indemnities. Organizations use this document to allocate risk, document consent, and set handling rules for sensitive test outputs. When prepared correctly it supports regulatory compliance and provides an auditable record of parties' rights and obligations during and after a testing engagement.

Why a Formal Release Document Matters

Using a Testing Release Document reduces ambiguity about data use, protects confidential information, and allocates liability between parties. It creates a clear record for audits or dispute resolution and helps demonstrate adherence to applicable laws such as the ESIGN Act and UETA when executed electronically.

Typical Users and Stakeholders

Typical users include product teams, legal counsel, quality assurance, and third-party testing vendors involved in controlled sharing of test materials.

Product managers and engineers who define test scope, acceptance criteria, and technical handling requirements.
Legal and compliance teams reviewing liability, confidentiality, and regulatory obligations.
Vendors or contractors receiving materials under limited license and non-disclosure terms.

Identifying the right participants early ensures appropriate approvals and reduces downstream legal or operational friction.

Core Sections to Include in a Professional Testing Release Document

Key sections in a Testing Release Document define scope, permitted use, confidentiality, data handling, liability allocation, and signatures to ensure enforceability and operational clarity.

Scope

Specify exactly what tests, datasets, prototypes, or results are covered, duration of access, geographic limits, and any excluded items. Clear scope prevents unintended use and narrows liability exposure.

Permitted Use

List allowed activities (analysis, internal review, integration testing) and prohibit redistribution, commercialization, or public disclosure without written permission. State whether derivative works are allowed and under what conditions.

Confidentiality

Define confidential categories, required handling practices, encryption standards, permitted disclosures to subcontractors, and required notices for breaches. Include duration of confidentiality obligations post-release.

Data Handling

Describe storage, transmission, destruction, and anonymization requirements. Specify encryption, access controls, logging, and any regulatory controls such as HIPAA when personal health information is involved.

Liability & Indemnity

Allocate responsibility for damages, limits on liability, indemnification obligations, and any insurance requirements. Include cap amounts and carve-outs for intentional misconduct or gross negligence.

Signatures & Dates

Identify authorized signatories, signature order, effective date, and whether electronic signatures are acceptable under ESIGN or UETA. Note notarization or witness needs if required.

Security and Compliance Facts to Note

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest.

Authentication: Multi-factor options; email and SMS codes.

Audit Trail: Timestamps, IP, action history retained.

HIPAA BAA: Available with signed BAA for PHI.

Certifications: SOC 2 Type II and ISO 27001.

Retention: Secure backups with configurable retention policies.

Step-by-Step: Prepare, Execute, and Record the Document

Follow these steps to prepare, execute, and record a Testing Release Document correctly to reduce legal and operational risk.

01

Draft Terms: Define scope, data handling, confidentiality, and liability clearly.
02

Identify Signatories: Confirm authorized signers and corporate authority.
03

Choose Signing Method: Select electronic or wet signature and authentication level.
04

Archive Record: Store signed copy with audit trail and access controls.

Configure an Online Signing Workflow

Configure the online workflow to collect signatures, attach exhibits, and enforce field validation for consistent execution.

Field	Configuration
Signature Method	Electronic signature with audit trail
Authentication Level	Email link, SMS code, or KBA as needed
Attachments	Allow PDFs, DOCX, and images as exhibits
Expiration	Set link expiry to a specific date or days

Typical e-Execution Flow for a Testing Release Document

Typical e-execution flow for a Testing Release Document, from upload to final storage, balancing signer experience and evidentiary needs.

Upload Document: Upload final PDF with labeled exhibits.
Place Fields: Add signature, date, and initial fields.
Send to Signers: Use email or secure link with authentication.
Store Copies: Save signed PDF and audit certificate in repository.

Platform Capabilities and Integration Considerations

Ensure platform supports required formats, authentication, and integrations before issuing the Testing Release Document.

File Formats: Support for PDF and Word DOCX formats.
Integrations: Salesforce, NetSuite, Google Workspace integrations available.
Security: TLS 1.2/1.3; AES-256 at rest.

Timing and Key Deadlines to Track

Key timing considerations include effective date, signature deadlines, retention triggers, and regulatory notification periods relevant to the release.

Effective Date:

When rights and obligations begin; enter as MM/DD/YYYY.

Signature Deadline:

Set a clear expiration for signing links or delivery.

Breach Notice Timing:

Specify required notification timeline after a security incident.

Record Retention Trigger:

Retention starts on creation or effective date as specified.

Review Cycle:

Periodic reassessment every 12–36 months recommended for long programs.

Common Mistakes to Avoid

Vague scope language that fails to describe exact datasets or prototypes, leading to disputes over covered materials and unintended disclosures.
Omitting authorized signatory verification and corporate authority checks, which can render the agreement unenforceable against an entity.
Failing to specify data handling or encryption requirements, risking noncompliance with HIPAA or contractual security expectations when PHI is involved.
Using inconsistent dates or multiple effective dates across exhibits, causing uncertainty about when obligations begin or expire.

Short List of Legal and Operational Risks

Contract Invalidity: Material defects may render agreement voidable.

Regulatory Fines: HIPAA violations can trigger penalties.

Liability Exposure: Uncapped indemnity increases financial risk.

Data Breach Costs: Notification and remediation expenses apply.

Business Interruption: Operational delays from unclear permissions.

Tax Withholding: Missing W-9 info triggers backup withholding.

E-Signature Vendor Snapshot Relevant to This Document

Compare core pricing and compliance features across common eSignature providers; signNow is listed first per vendor ordering rules.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial, no credit card required	No free trial	No free trial	Free limited trial	Free limited trial
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently Asked Questions and Practical Answers

Answers to frequent questions about executing, validating, and managing a Testing Release Document, including eSignature legality and retention considerations.

Need help? Contact support

Is an electronic signature valid?
Yes. Electronic signatures are legally valid for most Testing Release Documents under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA rules. Recognize statutory exceptions like wills or certain court filings before relying solely on e-signatures.
When is notarization required?
Notarization depends on state law and document purpose. Testing Release Documents rarely require notarization unless they affect real property, convey rights requiring formal acknowledgement, or include powers of attorney; confirm with the state notary authority.
What if signer names don't match?
Name mismatches can impair attribution and enforcement. Obtain government ID, correct the name via an amendment or notarized acknowledgement, and ensure tax reporting uses a completed W-9 to avoid backup withholding consequences.
How long must signed copies be kept?
Retention depends on content: IRS records generally require 3 years from filing (IRC §6501(a)); HIPAA requires 6 years for PHI (45 CFR §164.530(j)). Keep records longer where contract or state law requires it.
How to fix errors after signing?
Use a signed amendment or corrective addendum executed by all parties; do not alter the original signed document. For material changes, consult counsel to preserve enforceability and evidentiary integrity.
Can I use Remote Online Notarization?
Many states permit RON but requirements vary (identity proofing, audio-video recording, retention). Verify the state's RON rules and notary commission guidance before relying on remote notarization for evidentiary needs.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now